Covaxin effective against multiple variants of Covid-19: ICMR study
From May 1, the government has opened vaccination for all people above 18 years of age
Indigenously-developed Bharat Biotech's Covid-19 vaccine Covaxin neutralises multiple variants of SARS-CoV-2. Covaxin also effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said today.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more